Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?

Macroscopic complete resection (MCR) is the goal of surgery and seems to have the most significant effect on survival in patients undergoing surgery-directed multimodality treatment (MMT) for malignant pleural mesothelioma (MPM) (1). For the authors, it is not questionable that Dr. David J. Sugarbaker and his team had, have and will have a significant impact on the term MCR and the surgery-directed MMT, respectively.